Literature DB >> 17133260

Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study.

Simona Barlera1, Claudia Specchia, Martin Farrall, Benedetta D Chiodini, Maria Grazia Franzosi, Stephan Rust, Fiona Green, Enrico B Nicolis, John Peden, Gerd Assmann, Rory Collins, Anders Hamsten, Gianni Tognoni, Hugh Watkins.   

Abstract

The serum concentration of lipoprotein Lp (a) is known to be highly heritable and associated with cardiovascular risk. A genome-wide variance component linkage analysis was performed to localise quantitative trait loci (QTLs) influencing Lp(a) levels in a large cohort collected in the PROCARDIS coronary heart disease study. Highly significant linkage was detected at the previously described LP(a) locus on chromosome 6q27 (LOD 108). Taking into account the effect of the locus detected on chromosome 6, a highly significant LOD score was detected on chromosome 13q22-31 (LOD 7.0). Another significant region of linkage was observed on chromosomes 11p14-15 (LOD 3.5). The significant peak at 13q22-31 shows an essential overlap with a locus modulating cholesterol in familial hypercholesterolemia. If the gene underlying these loci is the same, it will be a promising candidate target for manipulating LDL-cholesterol and Lp(a). We also detected linkage at a previously identified locus influencing Lp(a) on chromosome 1q23 (LOD 1.5). Our findings provide new and confirmatory information about genomic regions involved in the quantitative variation of Lp(a) and serve as a basis for further studies of candidate genes in these regions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133260     DOI: 10.1038/sj.ejhg.5201732

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

Review 2.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

3.  Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

Authors:  Wensheng Lu; Yu-Ching Cheng; Keping Chen; Hong Wang; Glenn S Gerhard; Christopher D Still; Xin Chu; Rongze Yang; Ankita Parihar; Jeffrey R O'Connell; Toni I Pollin; Eduardo Angles-Cano; Michael J Quon; Braxton D Mitchell; Alan R Shuldiner; Mao Fu
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 6.150

4.  Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels.

Authors:  Sonia López; Alfonso Buil; Jordi Ordoñez; Juan Carlos Souto; Laura Almasy; Mark Lathrop; John Blangero; Francisco Blanco-Vaca; Jordi Fontcuberta; José Manuel Soria
Journal:  Eur J Hum Genet       Date:  2008-06-18       Impact factor: 4.246

Review 5.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

6.  LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.

Authors:  Wei-Qi Wei; Xiaohui Li; Qiping Feng; Michiaki Kubo; Iftikhar J Kullo; Peggy L Peissig; Elizabeth W Karlson; Gail P Jarvik; Ming Ta Michael Lee; Ning Shang; Eric A Larson; Todd Edwards; Christian M Shaffer; Jonathan D Mosley; Shiro Maeda; Momoko Horikoshi; Marylyn Ritchie; Marc S Williams; Eric B Larson; David R Crosslin; Sarah T Bland; Jennifer A Pacheco; Laura J Rasmussen-Torvik; David Cronkite; George Hripcsak; Nancy J Cox; Russell A Wilke; C Michael Stein; Jerome I Rotter; Yukihide Momozawa; Dan M Roden; Ronald M Krauss; Joshua C Denny
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

7.  Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA).

Authors:  Juan Zhao; QiPing Feng; Patrick Wu; Jeremy L Warner; Joshua C Denny; Wei-Qi Wei
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

8.  Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.

Authors:  Michael G Levin; Verena Zuber; Venexia M Walker; Derek Klarin; Julie Lynch; Rainer Malik; Aaron W Aday; Leonardo Bottolo; Aruna D Pradhan; Martin Dichgans; Kyong-Mi Chang; Daniel J Rader; Philip S Tsao; Benjamin F Voight; Dipender Gill; Stephen Burgess; Scott M Damrauer
Journal:  Circulation       Date:  2021-06-18       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.